Indeed, tumor control stopped only 1 week after the end of the NK cell injections, which may suggest that KLRC1KO NK cells have a very short life span in vivo, despite the presence of human IL-15 in the transgenic mice used. This evidence concerns the gene IL15 and neoplasm.